HIV Treatment Adherence in Women Living With HIV/AIDS: Research Based on the Information-Motivation-Behavioral Skills Model of Health Behavior

2001 ◽  
Vol 12 (4) ◽  
pp. 58-67 ◽  
Author(s):  
Seth C. Kalichman ◽  
David Rompa ◽  
Kari DiFonzo ◽  
Dolores Simpson ◽  
James Austin ◽  
...  
Keyword(s):  
Health Behavior ◽  
Treatment Adherence ◽  
Hiv Treatment ◽  
Behavioral Skills ◽  
Women Living With Hiv ◽  
Aids Research ◽  
Living With Hiv ◽  
Hiv Aids

Social Support, Positive States of Mind, and HIV Treatment Adherence in Men and Women Living With HIV/AIDS.

2004 ◽  
Vol 23 (4) ◽  
pp. 413-418 ◽  
Author(s):  
Jeffrey S. Gonzalez ◽  
Frank J. Penedo ◽  
Michael H. Antoni ◽  
Ron E. Durán ◽  
Shvawn McPherson-Baker ◽  
...  
Keyword(s):  
Social Support ◽  
Treatment Adherence ◽  
Hiv Treatment ◽  
States Of Mind ◽  
Men And Women ◽  
Women Living With Hiv ◽  
Living With Hiv ◽  
Hiv Aids

scholarly journals Race-based medical mistrust, medication beliefs and HIV treatment adherence: test of a mediation model in people living with HIV/AIDS

2016 ◽  
Vol 39 (6) ◽  
pp. 1056-1064 ◽  
Author(s):  
Seth C. Kalichman ◽  
Lisa Eaton ◽  
Moira O. Kalichman ◽  
Tama Grebler ◽  
Cynthia Merely ◽  
...  
Keyword(s):  
Treatment Adherence ◽  
Hiv Treatment ◽  
People Living With Hiv ◽  
Medical Mistrust ◽  
Mediation Model ◽  
Medication Beliefs ◽  
Adherence Test ◽  
Living With Hiv ◽  
Hiv Aids

scholarly journals The role of unintended pregnancy in internalized stigma among women living with HIV in Kenya

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Sara Chace Dwyer ◽  
Aparna Jain ◽  
Wilson Liambila ◽  
Charlotte E. Warren
Keyword(s):  
Unintended Pregnancy ◽  
Hiv Treatment ◽  
Outcome Variable ◽  
Internalized Stigma ◽  
Health Seeking ◽  
Logistic Regression Models ◽  
Stigma And Discrimination ◽  
Women Living With Hiv ◽  
Related Stigma ◽  
Living With Hiv

Abstract Background Kenya has successfully expanded HIV treatment, but HIV-related stigma and discrimination, and unintended pregnancy remain issues for many Kenyan women living with HIV. While HIV-related stigma can influence the health seeking behaviors of those living with HIV, less is known about how reproductive health outcomes influence internalized stigma among women living with HIV. Methods Baseline data only were used in this analysis and came from an implementation science study conducted in Kenya from 2015 to 2017. The analytic sample was limited to 1116 women who are living with HIV, between 18 to 44 years old, and have ever experienced a pregnancy. The outcome variable was constructed from 7 internalized stigma statements and agreement with at least 3 statements was categorized as medium/high levels of internalized stigma. Unintended pregnancy, categorized as unintended if the last pregnancy was mistimed or unwanted, was the key independent variable. Univariate and multivariate logistic regression models were used to assess the association between unintended pregnancy and internalized stigma. Associations between internalized stigma and HIV-related discrimination and violence/abuse were also explored. Results About 48% agreed with at least one internalized stigma statement and 19% agreed with at least three. Over half of women reported that their last pregnancy was unintended (59%). Within the year preceding the survey, 52% reported experiencing discrimination and 41% reported experiencing violence or abuse due to their HIV status. Women whose last pregnancy was unintended were 1.6 times (95% CI 1.2–2.3) more likely to have medium/high levels of internalized stigma compared to those whose pregnancy was wanted at the time, adjusting for respondents’ characteristics, experiences of discrimination, and experiences of violence and abuse. Women who experienced HIV-related discrimination in the past 12 months were 1.8 times (95% CI 1.3–2.6) more likely to have medium/high levels of internalized stigma compared to those who experienced no discrimination. Conclusions Results suggest that unintended pregnancy is associated with internalized stigma. Integrated HIV and FP programs in Kenya should continue to address stigma and discrimination while increasing access to comprehensive voluntary family planning services for women living with HIV.

scholarly journals Treatment adherence in patients living with HIV/AIDS assisted at a specialized facility in Brazil

2017 ◽  
Vol 50 (5) ◽  
pp. 607-612 ◽  
Author(s):  
Simone Miyada ◽  
Artênio José Ísper Garbin ◽  
Renata Colturato Joaquim Gatto ◽  
Cléa Adas Saliba Garbin
Keyword(s):  
Treatment Adherence ◽  
Living With Hiv ◽  
Hiv Aids

scholarly journals Increased chance of metabolic syndrome in women living with HIV/AIDS and lipodystrophic syndrome

2016 ◽  
Vol 49 (5) ◽  
pp. 421 ◽  
Author(s):  
Thiago Cândido Alves ◽  
Camila De Moraes ◽  
André Pereira dos Santos ◽  
Ana Cláudia Rossini Venturini ◽  
Rodrigo De Carvalho Santana ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Women Living With Hiv ◽  
Sindrome Metabolica ◽  
Terapia Antirretroviral ◽  
Living With Hiv ◽  
Total P ◽  
Lipodystrophic Syndrome ◽  
Hiv Aids

Modelo do estudo: Estudo de prevalência de corte transversal. Objetivo: comparar a sintomatologia critério para Síndrome Metabólica em homens e mulheres que vivem com HIV/aids, pacientes com Síndrome Lipoditrófica em terapia antirretroviral. Método: participaram do estudo 41 pacientes HIV positivos de ambos os sexos (18 a 69 anos), de um programa de orientação de exercício físico como terapia alternativa. Foi determinada a composição corporal total e regional por DXA, estatura, peso, circunferência de abdome, e determinação de parâmetros metabólicos (perfil lipídico e glicêmico) e imunológicos (detecção de carga viral e contagem de células T CD4+). Foram utilizados os critérios da IDF para o diagnóstico de SM. Resultados: As mulheres apresentaram maior gordura relativa (p = 0,001), obesidade central (p = 0,005), colesterol total (p = 0,043), LDL colesterol (p = 0,034) e contagem de CD4+ (p = 0,034) quando comparadas aos homens. Os valores médios para ambos os sexos apresentaram níveis elevados de triglicerídeos (> 211,4 mg.dL-1) e baixos de HDL (< 39,5 mg.dL- 1). A prevalência de Síndrome Metabólica nas mulheres foi duas vezes maior do que nos homens (p = 0,021), com significantes diferenças também na obesidade abdominal central (p = 0,005). Conclusões: A razão de prevalência (RP = 0,465) do sexo associado à Síndrome Metabólica indicou que as mulheres têm maior risco relativo e, portanto requerem ações alternativas na redução das chances de desenvolvimento desta síndrome

Sign in / Sign up

Export Citation Format

Share Document